Evidence map›Paper›PMID 26938991›Full record

ArticlePloS one2016

Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population.

Molly E Harmon, Matthew J Campen, Curtis Miller, Chris Shuey, Miranda Cajero, Selita Lucas, Bernadette Pacheco, Esther Erdei, Sandy Ramone, Teddy Nez and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Molly E HarmonDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Matthew J CampenDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Curtis MillerDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Chris ShueySouthwest Research and Information Center, Albuquerque, New Mexico, United States of America.
Miranda CajeroDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Selita LucasDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Bernadette PachecoDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Esther ErdeiDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
Sandy RamoneSouthwest Research and Information Center, Albuquerque, New Mexico, United States of America.
Teddy NezSouthwest Research and Information Center, Albuquerque, New Mexico, United States of America.
Johnnye LewisDepartment of Pharmaceutical Sciences and Community Environmental Health Program, University of New Mexico, Albuquerque, New Mexico, United States of America.
University of New Mexico · US

Funding

ZUNI KIDNEY PROJECT STUDY I--POPULATION BASED SURVEY OF RENAL DISEASEM01RR000997 · NCRR · UNIVERSITY OF NEW MEXICO · PI MERTZ, GREGORY JAMES · 1985 to 2010
$30.0M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Mechanisms of Vascular Toxicity from Inhaled ToxicantsR01ES014639 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J · 2008 to 2023
$6.7M
Navajo Uranium Assessment and Kidney Health ProjectR01ES014565 · NIEHS · UNIVERSITY OF NEW MEXICO · PI LEWIS, JOHNNYE L · 2006 to 2010
$2.4M
Dine'Network For Environmental Health (DiNEH) ProjectR25ES013208 · NIEHS · UNIVERSITY OF NEW MEXICO · PI LEWIS, JOHNNYE L · 2004 to 2007
$898k
Enhancement of Coronary Constriction by Volatile Organic Air ToxicsR56ES014639 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J · 2013 to 2013
$148k
NCATS NIH HHS UL1 TR000041NCRR NIH HHS M01 RR000997NCRR NIH HHS M01-RR-00997NHLBI NIH HHS HL00773620NIEHS NIH HHS ES013208NIEHS NIH HHS ES014565NIEHS NIH HHS ES014639NIEHS NIH HHS R01 ES014565NIEHS NIH HHS R01 ES014639NIEHS NIH HHS R25 ES013208NIEHS NIH HHS R56 ES014639
6 · The paper itself

Abstract

The prevalences of cardiovascular disease (CVD) and type 2 diabetes (T2D) have increased among the Navajo Native American community in recent decades. Oxidized low-density lipoprotein (oxLDL) is a novel CVD biomarker that has never been assessed in the Navajo population. We examined the relationship of oxLDL to conventional CVD and T2D risk factors and biomarkers in a cross-sectional population of Navajo participants. This cross-sectional study included 252 participants from 20 Navajo communities from the Diné Network for Environmental Health Project. Plasma samples were tested for oxLDL levels by a sandwich enzyme-linked immunosorbent assay. Univariate and multivariate analyses were used to determine the relationship of oxLDL and oxidized- to non-oxidized lipoprotein ratios to glycated hemoglobin (HbA1c), C-reactive protein (CRP), interleukin 6 (IL6) and demographic and health variables. Type 2 diabetes, hypertension and obesity are very prevalent in this Navajo population. HbA1c, CRP, body mass index (BMI), high-density lipoprotein, and triglycerides were at levels that may increase risk for CVD and T2D. Median oxLDL level was 47 (36.8-57) U/L. Correlational analysis showed that although oxLDL alone was not associated with HbA1c, oxLDL/HDL, oxLDL/LDL and CRP were significantly associated with HbA1c and glucose. OxLDL, oxLDL/HDL and oxLDL/LDL were significantly associated with CRP. Multivariate analysis showed that triglycerides were a common and strong predictor of oxLDL, oxLDL/HDL and oxLDL/LDL. OxLDL was trended with HbA1c and glucose but did not reach significance, however, HbA1c was an independent predictor of OxLDL/HDL. CRP trended with oxLDL/HDL and was a weak predictor of oxLDL/LDL. This Navajo subset appears to have oxLDL levels comparable to subjects without evidence of CVD reported in other studies. The high prevalence of T2D, hypertension and obesity along with abnormal levels of other biomarkers including HbA1c indicate that the Navajo population has a worsening CVD risk profile.

Indexed as

Indians, North AmericanAdultAgedBiomarkersBody Mass IndexC-Reactive ProteinCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypertensionInterleukin-6Lipoproteins, HDLLipoproteins, LDLMaleBiomarkersC-Reactive ProteinGlycated Hemoglobinhemoglobin A1c protein, humanIL6 protein, humanInterleukin-6Lipoproteins, HDLLipoproteins, LDLoxidized low density lipoprotein

Identifiers

PMID26938991
PMCPMC4777541
OpenAlexW2288793506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.